These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 36227854)

  • 1. Current treatments against mucormycosis and future directions.
    Smith C; Lee SC
    PLoS Pathog; 2022 Oct; 18(10):e1010858. PubMed ID: 36227854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Amphotericin B in the Treatment of Mucormycosis.
    Sachdeva A; Targhotra M; Chauhan MK; Chopra M
    Curr Pharm Des; 2024; 30(1):1-9. PubMed ID: 38178658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Part 2: mucormycosis: focus on therapy.
    Lynch JP; Zhanel GG
    Expert Rev Anti Infect Ther; 2023; 21(7):737-748. PubMed ID: 37300820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhino-orbito-cerebral mucormycosis: five cases.
    Toumi A; Larbi Ammari F; Loussaief C; Hadhri R; Ben Brahim H; Harrathi K; Ben Romdhane F; Koubaa J; Chakroun M
    Med Mal Infect; 2012 Dec; 42(12):591-8. PubMed ID: 23116703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhino-orbito-cerebral mucormycosis: a treatment dilemma.
    Jeevanan J; Gendeh BS; Faridah HA; Vikneswaran T
    Med J Malaysia; 2006 Mar; 61(1):106-8. PubMed ID: 16708746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease.
    Mezhir JJ; Mullane KM; Zarling J; Satoskar R; Pai RK; Roggin KK
    Surg Infect (Larchmt); 2009 Oct; 10(5):447-51. PubMed ID: 19485785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucormycosis: The hidden and forgotten disease.
    Darwish RM; AlMasri M; Al-Masri MM
    J Appl Microbiol; 2022 Jun; 132(6):4042-4057. PubMed ID: 35156271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
    Nair AG; Dave TV
    Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19.
    Sharma N; Wani SN; Behl T; Singh S; Zahoor I; Sehgal A; Bhatia S; Al-Harrasi A; Aleya L; Bungau S
    Environ Sci Pollut Res Int; 2023 Jan; 30(4):9164-9183. PubMed ID: 36454526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucormycosis: New Developments into a Persistently Devastating Infection.
    Danion F; Aguilar C; Catherinot E; Alanio A; DeWolf S; Lortholary O; Lanternier F
    Semin Respir Crit Care Med; 2015 Oct; 36(5):692-705. PubMed ID: 26398536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of mistaken identity:
    Chen AJ; Ediriwickrema LS; Verma R; Vavinskaya V; Shaftel S; Deconde AS; Korn BS; Kikkawa DO; Liu CY
    Orbit; 2021 Dec; 40(6):521-524. PubMed ID: 32862746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local injection of amphotericin B: novel use in the treatment of fungal maxillary sinusitis.
    Agarwal V; Kumia K; Gupta A; Singh V
    Int J Oral Maxillofac Surg; 2023 Dec; 52(12):1282-1285. PubMed ID: 37550130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Our 2014 approach to mucormycosis.
    Tacke D; Koehler P; Markiefka B; Cornely OA
    Mycoses; 2014 Sep; 57(9):519-24. PubMed ID: 24829170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare pediatric rhino-orbital infection caused by Saksenaea vasiformis.
    Taj-Aldeen SJ; Falamarzi A; AlMuzrkchi A; Guarro J
    Infection; 2012 Dec; 40(6):703-7. PubMed ID: 23001544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucormycosis.
    Reid G; Lynch JP; Fishbein MC; Clark NM
    Semin Respir Crit Care Med; 2020 Feb; 41(1):99-114. PubMed ID: 32000287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory rhino-orbito-cerebral mucormycosis treated with intraconal amphotericin B.
    Guimarães JA; Moura FC
    Arq Bras Oftalmol; 2022; 85(1):77-81. PubMed ID: 34468552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latest Thoughts on Treating Pediatric Mucormycosis.
    Steinbach WJ
    J Pediatric Infect Dis Soc; 2020 Nov; 9(5):640-644. PubMed ID: 33043976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.
    Luo G; Gebremariam T; Lee H; French SW; Wiederhold NP; Patterson TF; Filler SG; Ibrahim AS
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3340-7. PubMed ID: 23650163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanisms of Antifungal Resistance in Mucormycosis.
    Ganesan P; Ganapathy D; Sekaran S; Murthykumar K; Sundramoorthy AK; Pitchiah S; Shanmugam R
    Biomed Res Int; 2022; 2022():6722245. PubMed ID: 36277891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.